N-[(4E)-3,4-dihydro-2H-1-benzothiopyran-4-ylidene]hydroxylamine

Compound number
MolPort-000-917-635
CAS number
15857-68-8
IUPAC
N-[(4E)-3,4-dihydro-2H-1-benzothiopyran-4-ylidene]hydroxylamine
IUPAC traditional
N-[(4E)-2,3-dihydro-1-benzothiopyran-4-ylidene]hydroxylamine
SMILES
O\N=C1/CCSc2ccccc12
InChI key
RARVWGVWROHFMP-CSKARUKUSA-N
Molecular formula
Molecular weight
179.24
DMSO Solubility
Not known

Marketplace Offers

Angene (China)

Direct S&H to USA:
80.00 USD
Catalog
Building blocks
Ships out
10 business days
Purity
95%
Last updated
last week
In warehouse
5.57 g

Supplier Catalogue Data

Pack size Ships out Price Quantity
100 mg October 17, 2022 113.00 USD
Add to Cart Buy
250 mg October 17, 2022 195.00 USD
Add to Cart Buy
1 g October 17, 2022 388.00 USD
Add to Cart Buy

Fluorochem Limited

Direct S&H to USA:
95.00 USD
Catalog
Building blocks
Ships out
15 business days
Purity
95%
Last updated
> 3 months ago
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
250 mg October 24, 2022 197.34 USD
Add to Cart Buy
1 g October 24, 2022 489.06 USD
Add to Cart Buy
5 g October 24, 2022 1470.04 USD
Add to Cart Buy

Get your compounds in the right format

Molport Reweighting and Reformatting Services

More Information

Compound identifiers

Compound number
MolPort-000-917-635
CAS number
15857-68-8

Names, Synonyms and 3rd Party Identifiers

(E)-THIOCHROMAN-4-ONE OXIME
4-(hydroxyimino)-2H,3H-benzo[e]thiin
Thiochroman-4-one oxime
MFCD00024086

InChI

InChI
1/C9H9NOS/c11-10-8-5-6-12-9-4-2-1-3-7(8)9/h1-4,11H,5-6H2/b10-8+
InChI key
RARVWGVWROHFMP-CSKARUKUSA-N

Formula

Molecular formula
C9H9NOS
Molecular weight
179.24

Molport Guarantee

When you purchase products through the Molport website from any seller other than Molport itself, you will be protected by the Molport Guarantee. If you purchase products from Molport itself, this Molport Guarantee will not apply, and your remedies will be governed by the Molport Terms of Sale and Supply.

We use cookies to improve your experience on our websites and for advertising. By clicking "Accept All", you consent to our use of cookies. Learn more.

Feedback